• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23384 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Committee for New Health Technology Assessment (CNHTA) [Uterine tamponade of postpartal bleeding by ballooning catheter]
2009     Blue Cross Blue Shield Association (BCBS) Angioplasty and stenting of the cervical carotid artery with embolic protection of the cerebral circulation
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of everolimus to prevent renal transplant rejection]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Multi-slice computed tomography coronary angiography for coronary artery disease: a review of the clinical effectiveness and guidelines
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [The relationship between the cost-effectiveness of blood safety measures and the distribution of patients receiving blood]
2009     NIHR Health Technology Assessment programme Clinical and cost effectiveness of epoprostenol, iloprost, bosentan, sitaxentan, and sildenafil for the treatment of pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme Infliximab for the treatment of adults with psoriasis
2009     NIHR Health Technology Assessment programme Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009     NIHR Horizon Scanning Centre (NIHR HSC) Pirfenidone for idiopathic pulmonary fibrosis
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment of cerebrovascular disease]
2009     Committee for New Health Technology Assessment (CNHTA) [Radiofrequency(RF) ablation of high grade dysplastic nodule of the liver]
2009     Blue Cross Blue Shield Association (BCBS) Pharmacogenetic testing to predict serious toxicity from 5-Fluorouracil (5-FU) for patients administered 5-FU-based chemotherapy for cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Follow-up to 'The role of pharmacologic management in neovascular age- related macular degeneration: clinical and cost-effectiveness'
2009     NIHR Health Technology Assessment programme Zanamivir, oseltamivir and amantadine for the treatment of influenza (an update review of existing guidance)
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Fibrotest-Actitest: liver fibrosis diagnostic test for HCV patients
2009     NIHR Horizon Scanning Centre (NIHR HSC) Quetiapine (Seroquel XL) for major depressive disorder
2009     Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of digital mammography in breast cancer screening]
2009     Committee for New Health Technology Assessment (CNHTA) [Radiofrequency(RF) ablation of hepatocellular adenoma]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect calorimetry to measure energy requirements: a review of the guidelines and clinical effectiveness
2009     NIHR Health Technology Assessment programme Lapatinib for the treatment of HER2-overexpressing breast cancer
2009     NIHR Health Technology Assessment programme Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal
2009     Institute for Clinical Effectiveness and Health Policy (IECS) BAHA devices in hypoacusia
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for macular oedema secondary to central or branch retinal vein occlusion
2009     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of recombinant activated factor VII in nonhaemophilic patients]
2009     Committee for New Health Technology Assessment (CNHTA) [Anti-saccharomyces cerevisiae antibody test]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) C-reactive protein levels for cardiovascular disease screening: a review of accuracy, use, and guidelines
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2009     NIHR Health Technology Assessment programme Enhanced external counterpulsation for stable angina or heart failure: a systematic review and economic evaluation
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Utility of MuSK antibodies in patients with myastenia gravis
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for diabetic macular oedema
2009     Committee for New Health Technology Assessment (CNHTA) [SDHD gene, mutation[Sequencing]]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Chiropractic interventions for acute or chronic lower back pain in adults: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Rimonabant for the treatment of overweight and obese people
2009     NIHR Health Technology Assessment programme Non-occupational post-exposure prophylaxis for HIV
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Procalcitonin utility in hospitalized acute respiratory disease
2009     NIHR Horizon Scanning Centre (NIHR HSC) Retigabine for partial onset epilepsy - refractory
2009     Committee for New Health Technology Assessment (CNHTA) [SDHC gene, mutation[Sequencing]]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Alvimopan for surgical patients: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Infliximab for the treatment of ulcerative colitis
2009     NIHR Health Technology Assessment programme The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation
2009     Institute for Clinical Effectiveness and Health Policy (IECS) PUVA therapy: main dermatology applications
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sativex for adults experiencing pain from cancer
2009     Committee for New Health Technology Assessment (CNHTA) [SDHB gene, mutation[Sequencing]]
2009     NIHR Health Technology Assessment programme Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Photodynamic therapy for actinic keratosis treatment
2009     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) for transitional cell carcinoma of the urothelial tract - second line
2009     Committee for New Health Technology Assessment (CNHTA) [Hyoid myotomy suspension]
2009     The Swedish Council on Health Technology Assessment (SBU) [Transcranial magnetic stimulation in treating depression]
2009     NIHR Health Technology Assessment programme Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Detection of deamidated gliadin peptides for the diagnosis of celiac disease
2009     HAYES, Inc. Saw palmetto for benign prostatic hyperplasia
2009     NIHR Horizon Scanning Centre (NIHR HSC) Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
2009     Committee for New Health Technology Assessment (CNHTA) [Malaria antigen, rapid(target Ag:Aldolase,Histidine-rich protein-2)]
2009     NIHR Health Technology Assessment programme A systematic review of presumed consent systems for deceased organ donation
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Growth hormone in short children born small for gestational age
2009     NIHR Horizon Scanning Centre (NIHR HSC) Alipogene tiparvovec (AMT-011, Glybera) for lipoprotein lipase deficiency
2009     Committee for New Health Technology Assessment (CNHTA) [F12 gene, mutation[sequencing]]
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Immunoassay D-Dimer test as marker of venous thromboembolism
2009     NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) for neonates and infants with cyanotic congenital heart disease who have undergone a palliative shunt procedure
2009     Committee for New Health Technology Assessment (CNHTA) [F7 gene, mutation[sequencing]]
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for fludarabine-refractory chronic lymphocytic leukaemia - second or third-line
2009     Committee for New Health Technology Assessment (CNHTA) [IL2RG gene mutation analysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review of efficacy and safety in Cyberknife radiosurgery: indications and results in the treatment for intra and extracranial lesions]
2009     NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab (Xolair) for severe persistent allergic asthma in children
2009     Committee for New Health Technology Assessment (CNHTA) [SNCA Gene Mutation Anaysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Laparoscopic hysterectomy and lymphadenectomy efficacy and safety in endometrial cancer]
2009     University of York A systematic review of risk prediction rules in febrile neutropenic episodes in children and young people undergoing treatment for malignant disease (Protocol for a systematic review)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Silodosin for benign prostatic hyperplasia
2009     Committee for New Health Technology Assessment (CNHTA) [GFAP gene, mutation[sequencing]]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Photodynamic therapy effectiveness and safety in nonmelanoma skin cancer]
2009     Haute Autorite de sante (HAS) [Assessment of breast implants, tissue expanders and external breast prostheses]
2009     HAYES, Inc. Spinal cord stimulation for relief of neuropathic pain
2009     Committee for New Health Technology Assessment (CNHTA) [Continuous femoral nerve block]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Photodynamic therapy effectiveness, safety and cost-effectiveness in oesophagus cancer and Barrett oesophagus treatment]
2009     Medical Advisory Secretariat (MAS) Specialized multidisciplinary community-based care series: summary of evidence-based analyses
2009     HAYES, Inc. Stereotactic radiosurgery for arteriovenous malformations and intracranial tumors
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2009     Committee for New Health Technology Assessment (CNHTA) [Tonsillectomy with coblation]
2009     Medical Advisory Secretariat (MAS) Diabetes strategy evidence platform: summary of evidence-based analyses
2009     NIHR Horizon Scanning Centre (NIHR HSC) Agento I.C for ventilator associated pneumonia
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Fast-track surgery and enhanced recovery after surgery (ERAS) programs
2009     Committee for New Health Technology Assessment (CNHTA) [Pressure wire]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies : appropriate admission explicit criteria for heart failure (HF)]
2009     Medical Advisory Secretariat (MAS) Prevention and management of pressure ulcers: summary of evidence-based analyses
2009     NIHR Horizon Scanning Centre (NIHR HSC) Radachlorin photodynamic therapy for basal cell carcinoma
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Endoscopic thoracic sympathectomy
2009     Committee for New Health Technology Assessment (CNHTA) [TruScreen - cervical cancer screening system]
2009     Medical Advisory Secretariat (MAS) Intraocular lenses for the treatment of age-related cataracts: an evidence-based analysis
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Neoadjuvant radiochemotherapy for rectal cancer
2009     Committee for New Health Technology Assessment (CNHTA) [MUTYH gene mutation[Sequencing]]
2009     Medical Advisory Secretariat (MAS) Phakic intraocular lenses for the treatment of low to high refractive errors: an evidence-based analysis
2009     Belgian Health Care Knowledge Centre (KCE) Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: Rapid assessment
2009     Committee for New Health Technology Assessment (CNHTA) [ELA2 gene point mutation analysis]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Effectiveness, safety and indications of da Vinci Surgical System]
2009     Medical Advisory Secretariat (MAS) Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [NTRK1 gene point mutation analysis]
2009     Haute Autorite de sante (HAS) [Assessment of drug-eluting stents]
2009     Medical Advisory Secretariat (MAS) Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis
2009     Committee for New Health Technology Assessment (CNHTA) [CoaguChek XS PT TEST]